FDA’s decision on Logic gives way to concerns over pending PMTAs

The recent decision by the US Food and Drug Administration (FDA) on Logic’s products has raised some concerns among experts on how the federal agency will address the pending premarket tobacco product applications (PMTAs), Juul and Njoy among them.

The FDA has recently authorised the marketing of Logic’s several tobacco-flavoured e-cigarettes under its brands Logic Power and Logic Pro, whilst it denied others from the same company owned by Japan Tobacco International (JTI). At the same time, the agency stated that the decisions on other vendors’ PMTAs would be coming soon, including perhaps the long-awaited verdict on Juul.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization